David Mehalick

Insider Reports History

Location
Gibsonia, PA
Signature
/s/ David Mehalick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Mehalick:

Company Role Class Num Shares Value Price $ Report Date Ownership
Coeptis Therapeutics Holdings, Inc. CEO and President, Director, 10%+ Owner Common Stock 330,192 $4,748,160 $14.38 11 Feb 2026 Direct
Coeptis Therapeutics Inc. CEO and President, Director, 10%+ Owner Common Stock 1,800,000 16 Nov 2021 Direct
Coeptis Therapeutics Holdings, Inc. CEO and President, Director, 10%+ Owner Non-Qualified Stock Options (right to buy) 200,125 04 Mar 2025 Direct

Insider Reports Filed by David Mehalick

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COEP Coeptis Therapeutics Holdings, Inc. 11 Feb 2026 2 +$1,049,569 4 CEO and President, Director, 10%+ Owner 13 Feb 2026, 17:00
COEP Coeptis Therapeutics Holdings, Inc. 04 Mar 2025 1 $0 4 CEO and President, Director, 10%+ Owner 06 Mar 2025, 17:27
COEP Coeptis Therapeutics Holdings, Inc. 05 Jan 2024 3 +$16,747 4 CEO and President, Director, 10%+ Owner 09 Jan 2024, 17:30
COEP Coeptis Therapeutics Holdings, Inc. 07 Dec 2023 1 $0 4 CEO and President, Director, 10%+ Owner 11 Dec 2023, 16:01
COEP Coeptis Therapeutics Holdings, Inc. 27 Jan 2023 2 $0 4 CEO and President, Director, 10%+ Owner 31 Jan 2023, 09:59
COEP Coeptis Therapeutics Holdings, Inc. 28 Oct 2022 0 $0 3 CEO and President, Director, 10%+ Owner 07 Nov 2022, 12:58
COEP Coeptis Therapeutics Inc. 16 Nov 2021 1 $0 4 CEO and President, Director, 10%+ Owner 18 Nov 2021, 13:00